Serum direct bilirubin predicts severe tricuspid regurgitation in atrial fibrillation
Serum DBIL levels serve as a potential early diagnostic marker for moderate-to-severe TR in AF patients, and anti-infective therapy lowers TR incidence.
Authors
- Zhaoxia Wang (ORCID: https://orcid.org/0000-0001-7674-5488)
- Xinying Zou
- Daxin Zhou (ORCID: https://orcid.org/0000-0002-9926-5708)
- Yaosheng Wang (ORCID: https://orcid.org/0000-0002-2657-7057)
- Lin Da-wei
- Chunyan Shi (ORCID: https://orcid.org/0000-0002-7215-539X)
- Chenqing Wu (ORCID: https://orcid.org/0009-0003-3258-2869)
Institutions
- Shanghai Jiao Tong University (CN)
- Fudan University (CN)
- Renji Hospital (CN)
- XinHua Hospital (CN)
- Zhongshan Hospital (CN)
- Shanghai University of Medicine and Health Sciences (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-12-05
- DOI
- https://doi.org/10.3389/fcvm.2025.1691962
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Shanghai Jiao Tong University